What is epidermal nevus syndrome?
Epidermal nevus syndrome (ENS) is a rare condition characterised by thick, wart-like skin patches or streaks, known as epidermal nevi, which usually appear at birth or early childhood.1 Some children present with only these skin findings, while others also develop issues involving the bones, eyes, brain, or nervous system.2 Because multiple systems may be involved, ENS can look quite different from one child to another.2
ENS is extremely uncommon, and the exact prevalence is not known. Since symptoms can evolve gradually and affect several body systems, parents often describe the first months or years as confusing and emotionally demanding. Because of this uncertainty, families must receive clear explanations and have access to genetic counselling so they can plan for their child's care.
Most cases are not inherited, and children typically do not receive the condition from a parent. ENS frequently results from a gene mutation that happens after conception.2 This indicates that many families have a low risk of recurrence, but it is crucial to confirm this with a genetics team.
To treat children with ENS, a variety of specialists may be needed, including dermatologists (skin disease specialists), neurologists (brain and spinal cord disease specialists), ophthalmologists (eye disease specialists), orthopaedics (bone disease specialists), and genetic counsellors (gene mapping specialists). With appropriate planning and monitoring, many children manage well at home, in school, and in daily activities.
The role of genes in ENS
ENS is caused by alterations in particular genes that regulate the growth and development of skin, nerves, and other tissues. The most commonly affected genes include:
- FGFR3: It regulates cell division and growth. Bone changes and abnormal skin growths can result from alterations in this gene2
- PIK3CA: It controls cell signalling. Skin infection, tissue growth, and issues relating to the nervous system (brain and spinal cord) can all result from alterations in this gene3
- HRAS, KRAS, and NRAS: They control cell division and growth. When changed, they may result in the development of moles and, in rare instances, increase the risk of tumours4
Because these mutations often occur after conception, they may only affect a portion of the child’s cells (mosaicism). This explains why some children have only skin involvement, while others display neurological or musculoskeletal symptoms.
Genetic testing in ENS
Genetic testing can help confirm ENS and provide clarity for families. Testing options include:
- Skin biopsy: Since alterations might only exist in impacted skin cells, DNA from the skin lesion may be required to detect the genetic change
- Blood testing: If gene alterations are found in a greater percentage of cells, a biochemical analysis of blood may be required
- Next-generation sequencing (NGS): This is an advanced technique that detects mutations that may not be seen on standard tests
- Targeted gene panels: They can examine ENS-associated genes such as FGFR3, PIK3CA, and the RAS gene family2,3
Because ENS is a mosaic condition,5 before birth (during pregnancy) prenatal testing is usually not offered, as the mutation may be absent from reproductive cells. However, if a truly heritable mutation is identified, reproductive options can be discussed.
Genetic testing not only helps confirm the diagnosis but also guides future care and supports family planning.
Why does genetic counselling matter?
It can be very overwhelming to be diagnosed with ENS. Families frequently have a lot of questions:
- Will things get worse for my kid?
- Would this have an impact on future generations?
- What sort of long-term care will be required?
Genetic counselling offers trustworthy solutions and clarifies the science for families. It connects medical knowledge with practical decision-making. Crucially, it helps families make well-informed decisions regarding care and planning and provides reassurance when the likelihood of recurrence is low.
In addition to risk assessment, counselling helps families with planning. For example, parents can get advice on developmental therapies, school support, and long-term monitoring for seizures or bone lesions. Counsellors can also connect families with research opportunities and support networks to help them feel less alone on their journey.
What happens during a genetic counselling session?
The goal of a genetic counselling session is to direct, educate, and instruct families. It involves:2
- Review of medical and family history to look for patterns or suggestions of inheritance (if the condition runs in generations)
- Education about ENS, including its symptoms, genetic basis, and how the condition develops
- Discussion of genetic testing options, including their benefits and the limitations
- Interpretation of test results, helping families understand positive, negative, or uncertain findings
- Practical guidance on ongoing care, early interventions, support groups, and family planning2
Family planning and reproductive decisions
Even though ENS usually arises from non-heritable mosaic mutations, many families remain concerned about future pregnancies. Genetic counselling can clarify:
- Recurrence risk: typically low unless a mutation is detected in a parent’s germline (egg or sperm)
- Prenatal testing: possible only if a heritable, non-mosaic mutation is identified
- Preimplantation genetic testing (PGT): an option when a known heritable mutation is present
- Other family-building options include donor gametes or adoption
Counsellors help parents make informed, supported reproductive decisions.
Psychosocial and emotional support
Beyond physical health, ENS can influence emotional well-being, family life, school, and confidence. Family stress can be due to:
- Skin differences that are noticeable and draw unwanted attention
- Uncertainty about neurological (brain, spinal cord, nerves) or skeletal (muscle) issues
- Repeated doctor's appointments or procedures
Support strategies may include:
- Psychological counselling for parents or children
- Peer support groups that may help families connect with others facing similar challenges
- Educational support, especially if learning or social difficulties arise
Addressing emotional and social challenges is as important as managing the medical aspects of ENS.
FAQs
Is ENS inherited from parents?
ENS is typically not inherited. Usually, a mosaic mutation—in which the alteration is present in only a portion of the child's cells—causes it. The condition is usually not carried or passed on by parents.
Can genetic testing confirm ENS?
Yes. Genetic testing can detect mutations in genes such as FGFR3, PIK3CA, or RAS family genes through blood or skin biopsies. This will define recurrence risks and aid in treatment decisions.
Why is genetic counselling important?
With counselling, families can learn more about what ENS is, how it might impact the child, if future children are also at risk, and what types of resources are available for medical or educational support.
Does ENS affect life expectancy?
The majority of kids with ENS have a normal lifespan. Organ involvement, such as seizures or bone issues, is the primary cause for concern and necessitates routine monitoring.
Summary
ENS is a rare condition beginning with epidermal nevi and potentially involving the bones, eyes, and nervous system. Mutations in genes such as FGFR3, PIK3CA, and RAS family genes occur in a mosaic pattern, meaning only some cells are affected. Diagnosis often requires a combination of blood tests, skin biopsies, and NGS.
Genetic counselling is central to helping families understand the condition, interpret test findings, assess recurrence risk, and consider reproductive options. It also provides emotional and practical support, helping families navigate uncertainty and long-term care. With early diagnosis, coordinated multidisciplinary care, and ongoing guidance, many children with ENS can lead fulfilling, healthy lives.
References
- Epidermal nevus: MedlinePlus Genetics [Internet]. [cited 2025 Nov 21]. Available from: https://medlineplus.gov/genetics/condition/epidermal-nevus/.
- Nicholson CL, Daveluy S. Epidermal Nevus Syndromes. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Nov 21]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK559003/.
- Mirzaa G, Graham JM, Keppler-Noreuil K. PIK3CA-Related Overgrowth Spectrum. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2025 Nov 21]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK153722/.
- Dionysiou M, Makri SC, Ahlawat S, Guryildirim M, Barañano KW, Groves ML, et al. Case report: MEK inhibitor as treatment for multi-lineage mosaic KRAS G12D-associated epidermal nevus syndrome in a pediatric patient. Front Neurol [Internet]. 2024 [cited 2025 Nov 21]; 15:1466946. Available from: https://www.frontiersin.org/articles/10.3389/fneur.2024.1466946/full.
- Hafner C. Mosaicism of activatingFGFR3 mutations in human skin causes epidermal nevi. Journal of Clinical Investigation [Internet]. 2006 [cited 2025 Nov 21]; 116(8):2201–7. Available from: http://www.jci.org/cgi/doi/10.1172/JCI28163.

